Topical Antimicrobial TFM Needs A Clean Up – FDA Comments
This article was originally published in The Rose Sheet
Executive Summary
The Topical Antimicrobial Drug Products tentative final monograph provides little guidance to the topicals industry because it is geared towards antibiotics, according to the Centre for Research on Environmental Microbiology
You may also be interested in...
Antimicrobial monograph
FDA is reopening administrative record for OTC topical antimicrobial drug products monograph until Aug. 27 to accept comments and data on OTC healthcare antiseptic drugs, agency says in 1May 29 Federal Register notice. Record for TFM closed in August 1995, but agency has since received several petitions, comments containing new data on proposed non-monograph ingredients, testing criteria for antiseptic drugs. FDA will review new information because it is relevant to final ingredient classification and testing criteria, agency says. Comments previously submitted need not be resubmitted, and additional comments should only address data provided after August 1995. Triclosan, salicylic acid are among the ingredients requested by industry for Category I status; CTFA and SDA have submitted data on test protocols, antimicrobial performance, filing four petitions in 2001 alone (2"The Rose Sheet" Dec. 10, 2001, p. 4)...
Anti-Viral Indications For Antimicrobial Products Urged By CTFA/SDA
The Cosmetic, Toiletry and Fragrance Association and Soap and Detergent Association are proposing a two-step approach to allowing both anti-viral and antibacterial claims on personnel hand products, food handler products and consumer handwash products
OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program